Jeffrey, S., Chawla, S. P., Davidorf, O., Lande, S., Lingad, A., Xayasak, V., Ballon, J., Moradkhani, A. M., Kim, T., Chua-Alcala, V. S., Chawla, N. S., Gordon, E. M. (2026). A phase I/II study of safety/efficacy using lurbinectedin, combined with ipilimumab, and nivolumab, for advanced soft tissue sarcomas (NCT05876715).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps11599